1 Bilodeau PA,Coyne ES,Wing SS,et al.The ubiquitin proteasome system in atrophying skeletal muscle:roles and regulation[J].Am J Physiol Cell Physiol,2016,311(3):C392-403.

2 Peng Y,Liu Y,Gao Y,et al.USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis[J].J Exp Clin Cancer Res,2019,38(1):468.

3 Mapa CE,Arsenault HE,Conti MM,et al.A balance of deubiquitinating enzymes controls cell cycle entry[J].Mol Biol Cell,2018,29(23):2821-2834.

4 Liu J,Kruswick A,Dang H,et al.Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth[J].Nat Commun,2017,8(1):137.

5 He L,Liu X,Yang J,et al.Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR/PI3K/AKT drives breast carcinogenesis[J].Cell Res,2018,28(9):934-951.

6 Mansour MA.Ubiquitination:friend and foe in cancer[J].The International Journal of Biochemistry & Cell Biology,2018,101:80-93.

7 Baek KH.Conjugation and deconjugation of ubiquitin regulating the destiny of proteins[J].Exp Mol Med,2003,35(1):1-7.

8 Fraile JM,Manchado E,Lujambio A,et al.USP39 deubiquitinase is essential for KRAS oncogene-driven cancer[J].Journal of Biological Chemistry,2017,292(10):4164-4175.

9 Hu M,Li P,Li M,et al.Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde[J].Cell,2002,111(7):1041-1054.

10 李杨，宋平.泛素化/去泛素化系统的生物化学和生物学功能 [J].生命的化学，2006,26(6):515-517.

11 Dou Y,Lin J,Shu H,et al.Role of ubiquitin-specific peptidase 22 in carcinogenesis of human pharyngeal squamous cell carcinoma[J].Mol Med Rep,2014,10(6):2973-2978.

12 Zhuang YJ,Liao ZW,Yu HW,et al.ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma[J].Cancer Biology & Therapy,2015,16(1):88-96.

13 李丽娟，温树信，王斌全，等.肿瘤干细胞标记物USP22蛋白在喉鳞状细胞瘤中的表达及预后分析[J].中华耳鼻咽喉头颈外科杂志，2014,49(6):479-482.

14 Wang ML,Panasyuk G,Gwalter J,et al.Regulation of ribosomal protein S6 kinases by ubiquitination[J].Biochemical and biophysical research communications,2008,369(2):382-387.

15 Schwickart M,Huang X,Lill JR,et al.Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival[J].Nature,2010,463(7277):103-107.

16 Nanayakkara DM,Nguyen MN,Wood SA,et al.Deubiquitylating enzyme,USP9X,regulates proliferation of cells of head and neck cancer lines[J].Cell Prolif,2016,49(4):494-502.

17 Panasyuk G,Nemazanyy I,Filonenko V,et al.Ribosomal protein S6 kinase 1 interacts with and is ubiquitinated by ubiquitin ligase ROC1[J].Biochemical and Biophysical Research Communications,2008,369(2):339-343.

18 Khan OM,Carvalho J,Spencer-Dene B,et al.The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer[J].J Clin Invest,2018,128(4):1326-1337.

19 Chen X,Wu J,Chen Y,et al.Ubiquitin-specific protease 14 regulates cell proliferation and apoptosis in oral squamous cell carcinoma[J].The International Journal of Biochemistry & Cell Biology,2016,79:350-359.

20 Jiang L,Sun Y,Wang J,et al.Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma[J].J Exp Clin Cancer Res,2019,38(1):453.

21 Hou X,Wang L,Zhang L,et al.Ubiquitin-specific protease 4 promotes TNF-α-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma[J].FEBS Lett,2013,587(4):311-316.

22 Nicholson B,Suresh Kumar KG.The multifaceted roles of USP7:new therapeutic opportunities[J].Cell Biochem Biophys,2011,60(1-2):61-68.

23 Zhang MJ,Chen DS,Li H,et al.Clinical significance of USP7 and EZH2 in predicting prognosis of laryngeal squamous cell carcinoma and their possible functional mechanism[J].Int J Clin Exp Pathol,2019,12(6):2184-2194.

24 Yamagishi M,Uchimaru K.Targeting EZH2 in cancer therapy[J].Curr Opin Oncol,2017,29(5):375-381.

25 Tong Z,Cai M,Wang X,et al.EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin[J].Oncogene,2012,31(5):583-594.

26 da Silva SD,Cunha IW,Nishimoto IN,et al.Clinicopathological significance of ubiquitin-specific protease 2a (USP2a),fatty acid synthase (FASN),and ErbB2 expression in oral squamous cell carcinomas[J].Oral Oncol,2009,45(10):e134-e139.

27 Liu X,Kumar M,Yang L,et al.BAP1 Is a novel target in hpv-negative head and neck cancer[J].Clin Cancer Res,2018,24(3):600-607.

28 Yu H,Pak H,Hammond-Martel I,et al.Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair[J].Proceedings of the National Academy of Sciences,2014,111(1):285-290.

29 Varilla V,Atienza J,Dasanu CA ,et al.Immune alterations and immunotherapy prospects in head and neck cancer[J].Expert Opin Biol Ther,2013,13(9):1241-1256.

30 Klatka J,Hymos A,Szkatu?a-?upina A,et al.T-lymphocyte activation is correlated with the presence of anti-ebv in patients with laryngeal squamous cell carcinoma[J].In Vivo,2019,33(6):2007-2012.

31 Drop B,Strycharz-Dudziak M,Kliszczewska E,et al.Coinfection with epstein-barr virus (ebv),human papilloma virus (hpv) and polyoma bk virus (bkpyv) in laryngeal,oropharyngeal and oral cavity cancer[J].Int J Mol Sci,2017,18(12):1～13.

32 Whitehurst CB,Ning S,Bentz GL,et al.The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity[J].J Virol,2009,83(9):4345-4353.

33 Dyson OF,Pagano JS,Whitehurst CB,et al.The translesion polymerase pol η is required for efficient epstein-barr virus infectivity and is regulated by the viral deubiquitinating enzyme BPLF1[J].J Virol,2017,91(19):600-17.

34 Saito S,Murata T,Kanda T,et al.Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication[J].J Virol,2013,87(7):4060-4070.

35 Wu JJ,Guo WZ,Wen DH,et al.Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin-specific peptidase 9,X-linked in oral squamous cell carcinoma[J].Cancer Med,2018,7(8):4004-4011.

36 DiDonato JA,Mercurio F,Karin M,et al.NF-κB and the link between inflammation and cancer[J].Immunological Reviews,2012,246(1):379-400.

37 D'Arcy P,Wang X,Linder S,et al.Deubiquitinase inhibition as a cancer therapeutic strategy[J].Pharmacology & therapeutics,2015,147:32-54.

38 Poondla N,Chandrasekaran AP,Kim KS,et al.Deubiquitinating enzymes as cancer biomarkers:new therapeutic opportunities[J]?BMB Reports,2019,52(3):181-189.

39 Singh N,Singh AB.Deubiquitinases and cancer:a snapshot[J].Crit Rev Oncol Hematol,2016,103:22-26.

40 Mofers A,Pellegrini P,Linder S,et al.Proteasome-associated deubiquitinases and cancer[J].Cancer Metastasis Rev,2017,36(4):635-653.

41 Lee HR,Choi WC,Lee S,et al.Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein[J].Nature Structural & Molecular Biology,2011,18(12):1336-1348.

42 Tian ZD,Arcy P,Wang X,et al.A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance[J].Blood,2014,123(5):706-716.

43 Frappier L,Verrijzer CP.Gene expression control by protein deubiquitinases[J].Curr Opin Genet Dev,2011,21(2):207-213.

44 Bonacci T,Suzuki A,Grant GD,et al.Cezanne/OTUD7B is a cell cycle-regulated deubiquitinase that antagonizes the degradation of APC/C substrates[J].Embo J,2018,37(16):e98701.

45 Yeh C,Coyaud é,Bashkurov M,et al.The deubiquitinase usp37 regulates chromosome cohesion and mitotic progression[J].Curr Biol,2015,25(17):2290-2299.

46 Lecona E,Rodriguez-Acebes S,Specks J,et al.USP7 is a SUMO deubiquitinase essential for DNA replication[J].Nat Struct Mol Biol,2016,23(4):270-277.

47 Weber A,Heinlein M,Dengjel J,et al.The deubiquitinase Usp27x stabilizes the BH3-only protein bim and enhances apoptosis[J].EMBO Rep,2016,17(5):724-738.